SAN

80.34

-0.25%↓

UCB

269.7

+0.37%↑

SHL.DE

37.31

-1.43%↓

ARGX

674

+0.78%↑

VIE

34.81

+0.81%↑

SAN

80.34

-0.25%↓

UCB

269.7

+0.37%↑

SHL.DE

37.31

-1.43%↓

ARGX

674

+0.78%↑

VIE

34.81

+0.81%↑

SAN

80.34

-0.25%↓

UCB

269.7

+0.37%↑

SHL.DE

37.31

-1.43%↓

ARGX

674

+0.78%↑

VIE

34.81

+0.81%↑

SAN

80.34

-0.25%↓

UCB

269.7

+0.37%↑

SHL.DE

37.31

-1.43%↓

ARGX

674

+0.78%↑

VIE

34.81

+0.81%↑

SAN

80.34

-0.25%↓

UCB

269.7

+0.37%↑

SHL.DE

37.31

-1.43%↓

ARGX

674

+0.78%↑

VIE

34.81

+0.81%↑

Strona główna・Stock List・Vetoquinol SA

Vetoquinol SA

Closed

SectorHealthcare

76.7 -2.04

Buy Sell

Overview

Share price change

24h

Current

Min

76.4

Max

Key metrics
By Trading Economics
Income	25M
Sales	10M 268M
P/E Sector Avg	15.373 66.418
Profit margin	9.734
Employees	2,497
EBITDA	252M 301M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+42.86% upside

Market Stats
By TradingEconomics
Market Cap	-7.1M 928M
Previous open	78.74
Previous close	76.7

News Sentiment

By Acuity

50%

41 / 349 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

72.6 / 75.1 Support & Resistance

Vetoquinol SA Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

10 kwi 2026, 00:00 UTC

Major News Events

ADB: Higher Energy Prices to Raise Production, Consumer Costs

10 kwi 2026, 00:00 UTC

Major News Events

ADB Projects Japan GDP Growth at 0.7% in 2026, 0.6% in 2027

10 kwi 2026, 00:00 UTC

Major News Events

ADB Projects South Korea GDP Growth at 1.9% in 2026, 1.9% in 2027

10 kwi 2026, 00:00 UTC

Major News Events

Extent of Slowdown Hinges on Duration of MidEast Conflict, ADB Says

10 kwi 2026, 00:00 UTC

Major News Events

ADB Projects India GDP Growth at 6.9% in 2026, 7.3% in 2027

10 kwi 2026, 00:00 UTC

Major News Events

ADB Projects China GDP Growth at 4.6% in 2026, 4.5% in 2027

10 kwi 2026, 00:00 UTC

Major News Events

ADB Pojects Australia GDP Grrowth at 2.0% in 2026, 2.9% in 2027

10 kwi 2026, 00:00 UTC

Major News Events

ADB Projects Taiwan GDP Growth at 7.6% in 2026, 4.0% in 2027

10 kwi 2026, 00:00 UTC

Major News Events

Geopolitical Risks Make Asia's Economic Outlook Highly Uncertain, ADB Says

10 kwi 2026, 00:00 UTC

Major News Events

Asia Regional Growth Likely to Moderate in 2026-2027, ADB Says

9 kwi 2026, 23:44 UTC

Market Talk

Nikkei May Rise on Hopes for U.S.-Iran Talks -- Market Talk

9 kwi 2026, 23:34 UTC

Market Talk

Gold Edges Lower Amid Lingering Inflation Concerns -- Market Talk

9 kwi 2026, 23:14 UTC

Market Talk

Jefferies Upbeat on Australian Miners, But Recession a Key Risk -- Market Talk

9 kwi 2026, 23:14 UTC

Market Talk

Global Equities Roundup: Market Talk

9 kwi 2026, 23:07 UTC

Market Talk

Centaurus's Supply Deal with Glencore Supports Jaguar Development -- Market Talk

9 kwi 2026, 22:54 UTC

Market Talk

Transurban Lacks Appeal as Higher Fuel Prices Slow Traffic -- Market Talk

9 kwi 2026, 22:31 UTC

Major News Events

Trump on Truth Social: 'That Is Not the Agreement We Have!'

9 kwi 2026, 22:31 UTC

Major News Events

Trump on Truth Social: 'Iran Is Doing a Very Poor Job, Dishonorable Some Would Say, of Allowing Oil to Go Through the Strait of Hormuz'

9 kwi 2026, 20:57 UTC

Major News Events

U.S. Oil Prices Are Back Near $100 After Israel Keeps Up Air Strikes on Lebanon -- Barrons.com

9 kwi 2026, 20:55 UTC

Earnings

Stryker: Believes Incident Hasn't Had, and Isn't Reasonably Likely to Have, a Material Impact on 2026 Full-Year Guidance >SYK

9 kwi 2026, 20:55 UTC

Earnings

Stryker: Determined Incident Had Material Impact on Operations, With Resulting Impact on Financial Results for 1Q >SYK

9 kwi 2026, 20:55 UTC

Earnings

Stryker: Investigation of Cybersecurity Incident Remains Ongoing >SYK

9 kwi 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

9 kwi 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

9 kwi 2026, 20:40 UTC

Acquisitions, Mergers, Takeovers

Blackstone Investment Positions Rowan to Continue Delivering Sustainable Data Center Capacity for World's Leading Technology Cos >BX

9 kwi 2026, 20:39 UTC

Acquisitions, Mergers, Takeovers

Blackstone Blackstone Acquired Significant Minority Stake in Rowan Digital Infrastructure >BX

9 kwi 2026, 20:39 UTC

Acquisitions, Mergers, Takeovers

Rowan Digital Infrastructure Announces Strategic Recapitalization

9 kwi 2026, 20:25 UTC

Acquisitions, Mergers, Takeovers

SBA Communications Stock Soars on Buyout Interest. What It Means for Tower Stocks. -- Barrons.com

9 kwi 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

9 kwi 2026, 19:30 UTC

Major News Events

How Digital Currencies Have Helped Iran -- WSJ

Peer Comparison

Price change

Vetoquinol SA Forecast

Price Target

By TipRanks

42.86% upside

12 Months Forecast

Average 110 EUR 42.86%

High 110 EUR

Low 110 EUR

Based on 1 Wall Street analysts offering 12 month price targets forVetoquinol SA - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

1 ratings

Buy

Hold

Sell

Based on 1 analysts giving stock ratings to Vetoquinol SA - Dist in the past 3 months.

Technical Score

By Trading Central

72.6 / 75.1Support & Resistance

Recent bearish events outweigh bullish events.

All events are bearish.

Sentiment

By Acuity

41 / 349 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Vetoquinol SA

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.